Digitek Recall

A heart medication sold by Mylan Laboratories in the US has had to be recalled, after it emerged that some doses may contain twice the intended dose of active ingredient. Digitek (digoxin) is used to treat heart failure and cardiac arrhythmias, and the risk of adverse events with the drug is so serious that the US Food and Drug Administration (FDA) has take the unprecedented step of asking pharmacists to notify all patients who have been prescribed it. 

In a statement, Actavis Totowa, which manufacturers the product on a contract basis for Mylan, said that double strength tablets could pose a risk of toxicity, particularly in patients with renal failure.

Listen Now ~ Eric Pearson, a partner in the firm Heygood, Orr, Reyes, Pearson & Bartolomei in Dallas, talks about the recall with Scott Drake.